BackgroundMindfulness-Based Cognitive Therapy (MBCT) is a group intervention that integrates elements of Cognitive Behavioural Therapy (CBT) with components of mindfulness training to prevent depressive relapse. The efficacy of MBCT compared to Treatment As Usual (TAU), shown in two randomized controlled trials indicates a significant decrease in 1-year relapse rates for patients with at least three past depressive episodes. The present study is the first independent replication trial comparing MBCT + TAU to TAU alone across both language and culture (Swiss health care system).MethodsSixty unmedicated patients in remission from recurrent depression (≥ 3 episodes) were randomly assigned to MBCT + TAU or TAU. Relapse rate and time to relapse were measured over a 60 week observation period. The frequency of mindfulness practices during the study was also evaluated.ResultsOver a 14-month prospective follow-up period, time to relapse was significantly longer with MBCT + TAU than TAU alone (median 204 and 69 days, respectively), although both groups relapsed at similar rates. Analyses of homework adherence revealed that following treatment termination, the frequency of brief and informal mindfulness practice remained unchanged over 14 months, whereas the use of longer formal meditation decreased over time.LimitationsRelapse monitoring was 14 months in duration and prospective reporting of mindfulness practice would have yielded more precise frequency estimates compared to the retrospective methods we utilized.ConclusionsFurther studies are required to determine which patient characteristics, beyond the number of past depressive episodes, may predict differential benefits from this therapeutic approach.

The purpose of the present study was to explore the links among the four facets of impulsivity (urgency, lack of premeditation, lack of perseverance, and sensation seeking) proposed by and decision-making processes. Thirty undergraduate students completed a self-report questionnaire evaluating impulsivity as well as a task measuring decision-making processes, the Iowa Gambling Task. Zero-order correlations and multilevel analysis revealed that only lack of premeditation was specifically linked to disadvantageous decisions on the Gambling Task. This suggests that premeditation is related to decision making influenced by somatic (or emotional) markers.

Over the past few years, several questionnaires have been developed to measure mindfulness. The Mindful Attention Awareness Scale (MAAS) was created to specifically capture attention and awareness in daily life (Brown & Ryan, 2003). In this article, we present a French adaptation of the MAAS. In the 1st study, we explored the psychometric properties of this adaptation. In the 2nd study, we investigated its relation to cognitive emotion regulation and depressive symptomatology using path analysis. As in the original version of the MAAS, the French adaptation has a strong 1-factor structure. Moreover, there was a negative relationship between the MAAS and the severity of depressive symptoms, both directly and indirectly. The indirect pathway was mediated by the nonadaptive cognitive emotion regulation strategy of self-blame and the adaptive cognitive emotion regulation strategy of positive reappraisal. In conclusion, this questionnaire represents a valid mindfulness measure for French-speaking clinicians and researchers.

The main purpose of this study was to validate a French version of the Cognitive Emotion Regulation Questionnaire (CERQ). A sample of 224 young adults completed the French translation of the CERQ and the Beck Depression Inventory II. Exploratory and confirmatory factor analyses showed that a nine-factor model also explained the data collected with the French version. Internal reliability scores for each strategy ranged from .68 to .87. As in the original version, we found that the emotion regulation strategies could be grouped into adaptive and less adaptive cognitive regulation strategies. In addition, we observed that Self-blame and Rumination are key cognitive regulation strategies predicting whether high or low depressive symptoms are reported.

MBCT is feasible and well perceived among bipolar patients. Larger and randomized controlled studies are required to further evaluate its efficacy, in particular regarding depressive and (hypo)manic relapse prevention. The mediating role of mindfulness on clinical outcome needs further examination and efforts should be provided to enhance the persistence of meditation practice with time.

The White Bear Suppression Inventory (WBSI; Wegner & Zanakos, 1994) was originally designed to assess people's inclination toward thought suppression. In this article, we provide a detailed review of previous findings on the structure of this instrument and present a study that took a new statistical approach. It involved an exploratory factor analysis of the French WBSI using the weighted least squares mean and variance estimator as well as parametric item response theory analyses. Results clearly supported a 2-factor structure with a "suppression" and an "intrusion" dimension. Follow-up regression analyses revealed that intrusion significantly predicted anxiety and depression scores, whereas suppression did not.

Foa et al. (2002) presented a new instrument, the Obsessive-Compulsive Inventory-Revised (OCI-R), designed to evaluate the severity of obsessive-compulsive symptoms in both clinical and nonclinical individuals. The present study investigates the psychometric properties of a French version of this scale. The OCI-R French version was completed by 583 undergraduate students. The results revealed satisfactory internal consistency as measured by Cronbach's alpha coefficients (ranging from 0.63 to 0.86). In addition, the six-factor structure found by Foa et al. (2002) was confirmed in our sample by a confirmatory factor analysis. In brief, the French version of the OCI-R seems satisfactory for measuring Obsessive-Compulsive Disorders (OCD) symptoms in non-clinical samples. Future research is, however, needed to confirm these data in a sample of OCD patients.Recently, a new instrument, the Obsessive-Compulsive Inventory (OCI, Foa et al., 1998) was developed to overcome these limitations. This new scale was validated not only with OCD patients, but also with non-psychiatric controls. Thus, the scale is intended to be administered to both clinical and non-clinical individuals. Moreover, this inventory was specifically developed to assess the heterogeneous symptoms of OCD. From this perspective, the authors chose the main

No abstract